The purpose of this survey is to provide background material to assist AHCTA in developing recommendations for cell processing laboratory staff qualifications, training and competency. Please limit your responses to just those staff responsible for the processing of minimally manipulated products like hematopoietic progenitor cells (HPC) for stem cell transplantation and therapeutic cells (TC)- T cells.

Only a single response from each processing facility is required.

The following definitions apply in regards to this survey (please print this page for reference as you complete the survey if necessary):

Processing procedure: Manipulations of a cellular therapy product that occur on a single occasion. Examples of these include: depletion or enrichment of a product component (i.e. plasma, RBCs, MNC enrichment, CD34+ selection); cryopreservation; thawing; packaging for administration, transport or storage; and labeling. Note: A product that is plasma reduced, labeled, then cryopreserved would count as a single processing procedure. A product that is cryopreserved and then thawed at a later time would be considered as having undergone two processing procedures.
Processing Facility: A location where cellular therapy product processing activities are performed. A Processing Facility may be part of the same institution as a clinical program or may be part of another institution and perform these functions through contractual agreement.
Product: Standard of care or somatic cells used to restore hematopoiesis or used as therapeutic T cells obtained during a single collection (or harvesting) procedure.
Minimally manipulated product: Cells that have undergone processing that does not alter the relevant biological characteristics of the cells.
Somatic cell therapy product: Cells that are more than minimally manipulated. (See minimally manipulated).